ANTISENSE PHARMA GMBH
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 20, 2015 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 387 Total Citation Count
- Jan 29, 2002 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8822425 Dosage of oligonucleotides suitable for the treatment of tumorsMay 12, 09Sep 02, 14[C07H, C12N]
8476246 Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta systemJul 30, 10Jul 02, 13[C07H, A01N, C12Q, C12N]
8177775 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery techniqueFeb 14, 11May 15, 12[A61K, A61M]
8097597 Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumorsMay 04, 06Jan 17, 12[A61K, C07H]
7963956 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery techniqueApr 22, 03Jun 21, 11[A61K, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0208,774 METHOD FOR INHIBITING "MELANOMA INHIBITORY ACTIVITY" MIAAbandonedFeb 27, 12Aug 16, 12[A61K, C07K]
2011/0136,893 OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATESAbandonedDec 21, 07Jun 09, 11[A61K, C07H, A61P]
7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIAExpiredAug 11, 04Mar 22, 11[C07H, A61K, C12N]
2006/0128,607 Method for inhibiting "melanoma inhibitory activity" miaAbandonedJan 29, 02Jun 15, 06[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.